- Home
- ORMP vs JYNT Comparison
ORMP vs JYNT Comparison
Compare ORMP & JYNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ORMP | JYNT |
|---|---|---|
| Founded | 2002 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Multi-Sector Companies |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 141.3M | 120.7M |
| IPO Year | 2010 | 2014 |
Fundamental Metrics
Financial Performance| Metric | ORMP | JYNT |
|---|---|---|
| Price | $3.45 | $8.85 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $17.00 |
| AVG Volume (30 Days) | ★ 98.3K | 60.0K |
| Earning Date | 05-14-2026 | 05-07-2026 |
| Dividend Yield | ★ 7.27% | N/A |
| EPS Growth | ★ 412.50 | 133.93 |
| EPS | ★ 1.50 | 0.19 |
| Revenue | $2,000,000.00 | ★ $117,696,356.00 |
| Revenue This Year | N/A | $12.23 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $2.29 | $46.58 |
| Revenue Growth | ★ 49.25 | 15.49 |
| 52 Week Low | $1.82 | $7.50 |
| 52 Week High | $3.76 | $13.47 |
Technical Indicators
Market Signals| Indicator | ORMP | JYNT |
|---|---|---|
| Relative Strength Index (RSI) | 51.51 | 55.46 |
| Support Level | $3.21 | $8.46 |
| Resistance Level | $3.72 | $9.05 |
| Average True Range (ATR) | 0.17 | 0.28 |
| MACD | -0.01 | 0.08 |
| Stochastic Oscillator | 51.22 | 91.19 |
Price Performance
Historical ComparisonAbout ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.
About JYNT The Joint Corp.
The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The company has one operating business segment; The Franchise Operations segment, which is comprised of the operating activities of the franchise business unit. The Franchise Operations segment derives revenue from customers by providing access to the company's franchise license, which represents symbolic intellectual property.